We want to change the way iron deficiency anemia is treated, and chemotherapy-induced myelosuppression is prevented.

Explore our products

Monoferric® - ferric derisomaltose injection

Read about our intravenous iron.

COSELA® - trilaciclib injection 300mg

Read about our intravenous CDK 4/6 inhibitor for Extensive-Stage Small Cell Lung Cancer therapeutic space.

Pharmacosmos Therapeutics Inc is...

A leader in providing innovative treatments for unmet patient needs, with a focus on iron metabolism and blood related disorders.

Our science

Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders.

Iron deficiency anemia

Read about iron deficiency anemia.

Chemotherapy-induced myelosuppression

Read about chemotherapy-induced myelosuppression and its impact on extensive-stage small cell lung cancer patients.